Arima Ventin

Executive Director, Market Access, Pricing and Government Relations

Abbvie

Arima Ventin is strongly committed to the vision that healthcare companies should invest in therapies that fulfill unmet medical needs; engage the community in a positive way; and fill gaps in care in neglected therapeutic areas with a high impact on society. Arima is the Executive Director, Market Access, Pricing & Government Relations for Allergan Inc., an AbbVie Company, and has been in this role since August 2014. Prior to joining Allergan Arima was Director of Marketing and Market Access at Forest Laboratories, and Vice President of Marketing and Market Access at Basilea Pharmaceuticals Corp. Over the past 15 years she has held positions in sales, sales management, marketing, market research, analytics and strategic planning at Wyeth Pharmaceuticals and at Eli Lilly Canada. Arima is a member of the board of the Eczema Society of Canada and the IESE Alumni Association. Arima holds a B.Sc. in Pharmacy from the University of Toronto. Later, she earned her Master of Business Administration from the IESE School of Business at the University of Navarra in Barcelona, Spain. She is also a graduate of the IVEY Leadership Program at the Richard Ivey School of Business.


All Sessions by Arima Ventin

Printer Friendly See Full Agenda

Day 1: Oct 6, 2020

Day 2: Oct 7, 2020

11:05 am

11:05 am

Panel Discussion

Adapt Your Strategy to an Uncertain Marketplace and Succeed in Securing Public Payer PLA’s

Getting products listed for reimbursement with public payers can be challenging in a transitional, uncertain market.  Get the insight you need to meet the expectations of INESSS and the pCPA to navigate your new product through their submission processes.  Walk away with an action plan for your public PLA submission strategy by:

  • Understanding the types of products provinces need
  • Reviewing your value proposition to be sure it meets INESSS and pCPA expectations
  • Gaining valuable insight on any changes on the horizon for public PLA submission requirements

Position your company to succeed in an uncertain environment with a solid public PLA strategy

Day 3: Oct 8, 2020